SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-043342
Filing Date
2012-08-07
Accepted
2012-08-07 16:01:58
Documents
12
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v317418_10q.htm 10-Q 325392
2 EXHIBIT 10.3 v317418_ex10-3.htm EX-10.3 80315
3 EXHIBIT 31.1 v317418_ex31-1.htm EX-31.1 9337
4 EXHIBIT 31.2 v317418_ex31-2.htm EX-31.2 9169
5 EXHIBIT 32.1 v317418_ex32-1.htm EX-32.1 3773
6 EXHIBIT 32.2 v317418_ex32-2.htm EX-32.1 3763
  Complete submission text file 0001144204-12-043342.txt   2492011

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT chtp-20120630.xml EX-101.INS 231178
8 XBRL TAXONOMY EXTENSION SCHEMA chtp-20120630.xsd EX-101.SCH 27875
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE chtp-20120630_cal.xml EX-101.CAL 23464
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE chtp-20120630_def.xml EX-101.DEF 123066
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE chtp-20120630_lab.xml EX-101.LAB 227097
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chtp-20120630_pre.xml EX-101.PRE 158538
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51462 | Film No.: 121013233
SIC: 2836 Biological Products, (No Diagnostic Substances)